Consensus on clinical management of hepatitis B virus- infected women of childbearing age.
10.3760/cma.j.issn.1007-3418.2018.03.009
- VernacularTitle:感染乙型肝炎病毒的育龄女性临床管理共识
- Collective Name:Chinese Society of Hepatology, Chinese Medical Association
- Publication Type:Journal Article
- Keywords:
Consensus;
Hepatitis B virus;
Mother-to-child transmission;
Women of childbearing age
- MeSH:
Child;
Consensus;
Female;
Hepatitis B/virology*;
Hepatitis B Vaccines/administration & dosage*;
Hepatitis B virus;
Hepatitis B, Chronic/prevention & control*;
Humans;
Infant, Newborn;
Infectious Disease Transmission, Vertical/prevention & control*;
Pregnancy;
Pregnancy Complications, Infectious/prevention & control*
- From:
Chinese Journal of Hepatology
2018;26(3):204-208
- CountryChina
- Language:Chinese
-
Abstract:
The mother-to-child transmission(MTCT) of hepatitis B virus (HBV) is the dominant cause of chronic HBV infection. In order to achieve the goal of "zero" MTCT before pregnancy, during pregnancy, and after pregnancy; standardized management for hepatitis HBV infection in women of childbearing age should be regulated. The content of this consensus includes: screening and treatment of HBV in pregnant women and women of childbearing age, treatment of hepatitis B during pregnancy, preventive measures and evaluation of combined immunization of hepatitis B immunoglobulin and hepatitis B vaccine in newborns, anti-viral therapy for all pregnant women with a high HBV DNA level and post-partum period related management. In addition, 16 recommendations were formed for clinicians to standardize the clinical management of HBV infection in women of child-bearing age.
